These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 31184223)
1. Mechanistic complexities of bone loss in Alzheimer's disease: a review. Frame G; Bretland KA; Dengler-Crish CM Connect Tissue Res; 2020 Jan; 61(1):4-18. PubMed ID: 31184223 [No Abstract] [Full Text] [Related]
2. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease. Dengler-Crish CM; Ball HC; Lin L; Novak KM; Cooper LN Neurobiol Aging; 2018 Jul; 67():148-158. PubMed ID: 29660685 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and its associated risk of bone fractures: a narrative review. Zhou BN; Zhang Q; Li M Front Endocrinol (Lausanne); 2023; 14():1190762. PubMed ID: 37635980 [TBL] [Abstract][Full Text] [Related]
5. Aging and Alzheimer's disease pathology. Sengoku R Neuropathology; 2020 Feb; 40(1):22-29. PubMed ID: 31863504 [TBL] [Abstract][Full Text] [Related]
6. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
7. Role of tau protein in Alzheimer's disease: The prime pathological player. Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025 [TBL] [Abstract][Full Text] [Related]
8. Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease. de Freitas GB; Lourenco MV; De Felice FG J Neurochem; 2020 Dec; 155(6):602-611. PubMed ID: 32396989 [TBL] [Abstract][Full Text] [Related]
9. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease. Jia L; Piña-Crespo J; Li Y Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553 [TBL] [Abstract][Full Text] [Related]
10. Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease. Madhu LN; Somayaji Y; Shetty AK Ageing Res Rev; 2022 Jun; 78():101637. PubMed ID: 35504553 [TBL] [Abstract][Full Text] [Related]
11. Move Your Body toward Healthy Aging: Potential Neuroprotective Mechanisms of Irisin in Alzheimer's Disease. Bellettini-Santos T; Batista-Silva H; Marcolongo-Pereira C; Quintela-Castro FCA; Barcelos RM; Chiepe KCMB; Rossoni JV; Passamani-Ambrosio R; da Silva BS; Chiarelli-Neto O; Garcez ML Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569815 [TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in Alzheimer's disease: up or down, that is the question. Boonen RA; van Tijn P; Zivkovic D Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658 [TBL] [Abstract][Full Text] [Related]
13. The TRPM2 channel nexus from oxidative damage to Alzheimer's pathologies: An emerging novel intervention target for age-related dementia. Jiang LH; Li X; Syed Mortadza SA; Lovatt M; Yang W Ageing Res Rev; 2018 Nov; 47():67-79. PubMed ID: 30009973 [TBL] [Abstract][Full Text] [Related]
14. Molecular and Functional Interaction of the Myokine Irisin with Physical Exercise and Alzheimer's Disease. Jin Y; Sumsuzzman DM; Choi J; Kang H; Lee SR; Hong Y Molecules; 2018 Dec; 23(12):. PubMed ID: 30544500 [TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
16. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease. Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM; Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
18. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms. Hampel H J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423 [TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signaling in Alzheimer's disease. De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184 [TBL] [Abstract][Full Text] [Related]